Barbara Ann Burtness, MD of Yale Cancer Center explains the use of bevacizumab plus chemotherapy for the treatment of patients with metastatic head and neck cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Should Avastin (bevacizumab) be added to chemotherapy for the treatment of metastatic head and neck cancers?
